Longitudinal preclinical magnetic resonance imaging of diffuse tumor burden in intramedullary myeloma following bortezomib therapy-Reference-Cited by-同舟云学术

Longitudinal preclinical magnetic resonance imaging of diffuse tumor burden in intramedullary myeloma following bortezomib therapy

Author:

Hathi Deep K.¹²,Engelbach John A.²,Hillengass Jens³,Veis Deborah⁴,Achilefu Samuel¹²⁵⁶,Garbow Joel R.²⁶,Shokeen Monica¹²⁶^ORCID

Affiliation:

1. Department of Biomedical Engineering; Washington University in St. Louis; St. Louis MO USA

2. Department of Radiology; Washington University School of Medicine; St. Louis MO USA

3. Department of Oncology; Roswell Park Comprehensive Cancer Institute; Buffalo NY USA

4. Department of Pathology and Immunology; Washington University School of Medicine; St. Louis MO USA

5. Department of Biochemistry and Biophysics; Washington University School of Medicine; St. Louis MO USA

6. Alvin J. Siteman Cancer Center at Washington University School of Medicine and Barnes Jewish Hospital; St. Louis MO USA

Funder

Center for Scientific Review

NCI funded Center for Multiple Myeloma Nanotherapy

Small-Animal Cancer Imaging Shared Resource of the Alvin J. Siteman Cancer Center, an NCI-designated Comprehensive Cancer Center

Alafi Neuroimaging Laboratory, the Hope Center for Neurological Disorders, and NIH Shared Instrumentation

Publisher

Wiley

Subject

Spectroscopy,Radiology Nuclear Medicine and imaging,Molecular Medicine

Link

Reference23 articles.

2. Multiple myeloma;Palumbo;N Engl J Med,2011